ATE146674T1 - Pharmazeutische zusammensetzung zur rektalen verabreichung von wirkstoffen mit topischer medizinischer wirkung im dickdarmniveau - Google Patents
Pharmazeutische zusammensetzung zur rektalen verabreichung von wirkstoffen mit topischer medizinischer wirkung im dickdarmniveauInfo
- Publication number
- ATE146674T1 ATE146674T1 AT91201485T AT91201485T ATE146674T1 AT E146674 T1 ATE146674 T1 AT E146674T1 AT 91201485 T AT91201485 T AT 91201485T AT 91201485 T AT91201485 T AT 91201485T AT E146674 T1 ATE146674 T1 AT E146674T1
- Authority
- AT
- Austria
- Prior art keywords
- rectal administration
- pharmaceutical composition
- active ingredients
- medical effects
- intestinal level
- Prior art date
Links
- 210000001072 colon Anatomy 0.000 title abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 2
- 239000004480 active ingredient Substances 0.000 title 1
- 230000000694 effects Effects 0.000 title 1
- 230000000968 intestinal effect Effects 0.000 title 1
- 230000000699 topical effect Effects 0.000 title 1
- 239000012530 fluid Substances 0.000 abstract 1
- 239000006260 foam Substances 0.000 abstract 1
- 229940126702 topical medication Drugs 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0031—Rectum, anus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/12—Aerosols; Foams
- A61K9/122—Foams; Dry foams
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Dispersion Chemistry (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines Containing Plant Substances (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT02110490A IT1243379B (it) | 1990-07-27 | 1990-07-27 | Composizione farmaceutica adatta alla somministrazione rettale di principi attivi che esplicano un'azione di medicazione a livello del colon prevalentemente di tipo topico |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE146674T1 true ATE146674T1 (de) | 1997-01-15 |
Family
ID=11176813
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT91201485T ATE146674T1 (de) | 1990-07-27 | 1991-06-14 | Pharmazeutische zusammensetzung zur rektalen verabreichung von wirkstoffen mit topischer medizinischer wirkung im dickdarmniveau |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US5449520A (de) |
| EP (1) | EP0468555B2 (de) |
| JP (1) | JP3291301B2 (de) |
| AT (1) | ATE146674T1 (de) |
| CA (1) | CA2044676C (de) |
| DE (1) | DE69123795T3 (de) |
| DK (1) | DK0468555T4 (de) |
| ES (1) | ES2097787T5 (de) |
| GR (2) | GR3022790T3 (de) |
| IT (1) | IT1243379B (de) |
Families Citing this family (49)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9414699D0 (en) * | 1994-07-21 | 1994-09-07 | Slagel David | Aqueous foamable composition |
| DE4446891A1 (de) * | 1994-12-27 | 1996-07-04 | Falk Pharma Gmbh | Stabile wäßrige Budesonid-Lösung |
| CA2212046A1 (en) * | 1995-02-02 | 1996-08-08 | Chugai Seiyaku Kabushiki Kaisha | Sucralfate preparations |
| BR9609307B1 (pt) | 1995-06-27 | 2010-03-09 | preparação farmacêutica para produção de aerossóis inaláveis isentos de propelentes para administração nos pulmões, bem como aerossol compreendendo a mesma. | |
| IT1277663B1 (it) * | 1995-09-28 | 1997-11-11 | Crinos Industria Farmaco | Sospensioni acquose stabili di mesalazina per uso topico |
| US7135191B2 (en) * | 1997-09-04 | 2006-11-14 | Zsolt Istvan Hertelendy | Urogenital or anorectal transmucosal vaccine delivery system |
| US6239120B1 (en) | 1998-03-17 | 2001-05-29 | Pharmalink Ab | Method and means for treating glomerulonephritis |
| US6326364B1 (en) | 1999-02-08 | 2001-12-04 | Cedars-Sinai Medical Center | Use of 5-aminosalicylates as antimicrobial agents |
| DE19941933A1 (de) * | 1999-09-03 | 2001-03-15 | Cognis Deutschland Gmbh | Tensidsysteme |
| US8512718B2 (en) | 2000-07-03 | 2013-08-20 | Foamix Ltd. | Pharmaceutical composition for topical application |
| EP1312368A1 (de) * | 2001-11-19 | 2003-05-21 | Dr. Falk Pharma Gmbh | Zusammensetzungen enthaltend Mesalazin zur Behandlung von entzündlichen Darmerkrankungen |
| US20060140984A1 (en) | 2002-10-25 | 2006-06-29 | Foamix Ltd. | Cosmetic and pharmaceutical foam |
| IL152486A0 (en) | 2002-10-25 | 2003-05-29 | Meir Eini | Alcohol-free cosmetic and pharmaceutical foam carrier |
| US8119150B2 (en) | 2002-10-25 | 2012-02-21 | Foamix Ltd. | Non-flammable insecticide composition and uses thereof |
| US7704518B2 (en) | 2003-08-04 | 2010-04-27 | Foamix, Ltd. | Foamable vehicle and pharmaceutical compositions thereof |
| US9668972B2 (en) * | 2002-10-25 | 2017-06-06 | Foamix Pharmaceuticals Ltd. | Nonsteroidal immunomodulating kit and composition and uses thereof |
| US7700076B2 (en) | 2002-10-25 | 2010-04-20 | Foamix, Ltd. | Penetrating pharmaceutical foam |
| US7820145B2 (en) | 2003-08-04 | 2010-10-26 | Foamix Ltd. | Oleaginous pharmaceutical and cosmetic foam |
| US9265725B2 (en) | 2002-10-25 | 2016-02-23 | Foamix Pharmaceuticals Ltd. | Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof |
| US10117812B2 (en) | 2002-10-25 | 2018-11-06 | Foamix Pharmaceuticals Ltd. | Foamable composition combining a polar solvent and a hydrophobic carrier |
| US8119109B2 (en) | 2002-10-25 | 2012-02-21 | Foamix Ltd. | Foamable compositions, kits and methods for hyperhidrosis |
| US8900554B2 (en) | 2002-10-25 | 2014-12-02 | Foamix Pharmaceuticals Ltd. | Foamable composition and uses thereof |
| US20080138296A1 (en) | 2002-10-25 | 2008-06-12 | Foamix Ltd. | Foam prepared from nanoemulsions and uses |
| US8486376B2 (en) | 2002-10-25 | 2013-07-16 | Foamix Ltd. | Moisturizing foam containing lanolin |
| US9211259B2 (en) | 2002-11-29 | 2015-12-15 | Foamix Pharmaceuticals Ltd. | Antibiotic kit and composition and uses thereof |
| US7575739B2 (en) | 2003-04-28 | 2009-08-18 | Foamix Ltd. | Foamable iodine composition |
| JP2005015365A (ja) * | 2003-06-25 | 2005-01-20 | Koike Kagaku Kk | エアゾール型洗浄消毒剤 |
| US8486374B2 (en) | 2003-08-04 | 2013-07-16 | Foamix Ltd. | Hydrophilic, non-aqueous pharmaceutical carriers and compositions and uses |
| US8795693B2 (en) | 2003-08-04 | 2014-08-05 | Foamix Ltd. | Compositions with modulating agents |
| WO2007082698A1 (en) * | 2006-01-19 | 2007-07-26 | Disphar International B.V. | Foam-forming composition |
| US20080260655A1 (en) | 2006-11-14 | 2008-10-23 | Dov Tamarkin | Substantially non-aqueous foamable petrolatum based pharmaceutical and cosmetic compositions and their uses |
| US7645801B2 (en) | 2007-01-29 | 2010-01-12 | Alaven Pharmaceutical Llc | Reduced irritant enema for treatment of inflammatory bowel disease (IBD) |
| US8636982B2 (en) | 2007-08-07 | 2014-01-28 | Foamix Ltd. | Wax foamable vehicle and pharmaceutical compositions thereof |
| WO2009069006A2 (en) | 2007-11-30 | 2009-06-04 | Foamix Ltd. | Foam containing benzoyl peroxide |
| WO2010041141A2 (en) | 2008-10-07 | 2010-04-15 | Foamix Ltd. | Oil-based foamable carriers and formulations |
| WO2009072007A2 (en) | 2007-12-07 | 2009-06-11 | Foamix Ltd. | Carriers, formulations, methods for formulating unstable active agents for external application and uses thereof |
| AU2009205314A1 (en) | 2008-01-14 | 2009-07-23 | Foamix Ltd. | Poloxamer foamable pharmaceutical compositions with active agents and/or therapeutic cells and uses |
| US20120087872A1 (en) | 2009-04-28 | 2012-04-12 | Foamix Ltd. | Foamable Vehicles and Pharmaceutical Compositions Comprising Aprotic Polar Solvents and Uses Thereof |
| CA2769677A1 (en) | 2009-07-29 | 2011-02-03 | Foamix Ltd. | Non surface active agent non polymeric agent hydro-alcoholic foamable compositions, breakable foams and their uses |
| WO2011013009A2 (en) | 2009-07-29 | 2011-02-03 | Foamix Ltd. | Non surfactant hydro-alcoholic foamable compositions, breakable foams and their uses |
| AU2010302350B2 (en) | 2009-10-02 | 2015-06-18 | Journey Medical Corporation | Surfactant-free water-free foamable compositions, breakable foams and gels and their uses |
| US9849142B2 (en) | 2009-10-02 | 2017-12-26 | Foamix Pharmaceuticals Ltd. | Methods for accelerated return of skin integrity and for the treatment of impetigo |
| EP2503989A2 (de) | 2009-11-23 | 2012-10-03 | Cipla Limited | Topische schaumzusammensetzung |
| BR112012012315A2 (pt) | 2009-11-23 | 2018-10-16 | Cipla Ltd | composição farmacêutica para administração retal tópica na forma de espuma, uso de uma composição farmacêutica, método para tratamento, prevenção ou alívio de um dustúrbio no reto, cólon, íleo terminal ou anus, processo para fabricação de uma composição farmacêutica contendo rifaximina, uso de silicone e dispensador para composição farmacêutica |
| US8174881B2 (en) | 2009-11-24 | 2012-05-08 | Micron Technology, Inc. | Techniques for reducing disturbance in a semiconductor device |
| US12661407B2 (en) | 2010-04-08 | 2026-06-23 | Journey Medical Corporation | Compositions, gels and foams with rheology modulators and uses thereof |
| PT3115037T (pt) | 2015-07-08 | 2018-10-22 | Dr Falk Pharma Gmbh | Formulação farmacêutica para o tratamento de alterações inflamatórias do reto |
| MX2020012139A (es) | 2016-09-08 | 2021-01-29 | Vyne Pharmaceuticals Inc | Composiciones y metodos para tratar rosacea y acne. |
| US20190351060A1 (en) * | 2016-12-16 | 2019-11-21 | Ferring B.V. | Rectal Foam Formulations |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0015334B1 (de) * | 1977-08-04 | 1982-05-19 | J.B. Tillott Limited | Pfefferminzöl oder dessen aktive Bestandteile enthaltende Carminativa |
| JPS5921613A (ja) * | 1982-07-28 | 1984-02-03 | Takeda Chem Ind Ltd | 直腸投与製剤 |
| US4664256A (en) * | 1983-09-06 | 1987-05-12 | Farmaceutisk Laboratorium Ferring A/S | Packaged stable enema solution or suspension containing 5-aminosalicyclic acid |
| US4609403A (en) * | 1984-03-12 | 1986-09-02 | Warner-Lambert Company | Foam soft gelatin capsules and their method of manufacture |
| US4814183A (en) * | 1987-08-31 | 1989-03-21 | Merck & Co., Inc. | Device for the controlled release of drugs with Donnan-like modulation by charged insoluble resins |
| US5206268A (en) * | 1988-08-16 | 1993-04-27 | Burroughs Wellcome Co. | Medicaments |
| GB8909559D0 (en) * | 1989-04-26 | 1989-06-14 | Smith Kline French Lab | Pharmaceutical compositions |
| FR2647344B1 (fr) * | 1989-05-25 | 1995-06-02 | Physiopharm Sarl | Mousse aerosol a usage rectal |
-
1990
- 1990-07-27 IT IT02110490A patent/IT1243379B/it active IP Right Grant
-
1991
- 1991-06-14 AT AT91201485T patent/ATE146674T1/de not_active IP Right Cessation
- 1991-06-14 DE DE69123795T patent/DE69123795T3/de not_active Expired - Lifetime
- 1991-06-14 DK DK91201485T patent/DK0468555T4/da active
- 1991-06-14 CA CA002044676A patent/CA2044676C/en not_active Expired - Lifetime
- 1991-06-14 ES ES91201485T patent/ES2097787T5/es not_active Expired - Lifetime
- 1991-06-14 EP EP91201485A patent/EP0468555B2/de not_active Expired - Lifetime
- 1991-06-26 JP JP18059991A patent/JP3291301B2/ja not_active Expired - Lifetime
-
1993
- 1993-10-01 US US08/130,624 patent/US5449520A/en not_active Expired - Lifetime
-
1997
- 1997-03-11 GR GR970400474T patent/GR3022790T3/el unknown
-
2001
- 2001-03-23 GR GR20010400479T patent/GR3035634T3/el not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| DK0468555T4 (da) | 2001-04-02 |
| GR3035634T3 (en) | 2001-06-29 |
| IT1243379B (it) | 1994-06-10 |
| DE69123795T2 (de) | 1997-07-10 |
| EP0468555A1 (de) | 1992-01-29 |
| IT9021104A0 (it) | 1990-07-27 |
| CA2044676A1 (en) | 1992-01-28 |
| EP0468555B1 (de) | 1996-12-27 |
| EP0468555B2 (de) | 2001-02-07 |
| CA2044676C (en) | 2003-04-01 |
| JPH04234315A (ja) | 1992-08-24 |
| DE69123795D1 (de) | 1997-02-06 |
| DE69123795T3 (de) | 2001-07-12 |
| ES2097787T3 (es) | 1997-04-16 |
| GR3022790T3 (en) | 1997-06-30 |
| US5449520A (en) | 1995-09-12 |
| JP3291301B2 (ja) | 2002-06-10 |
| ES2097787T5 (es) | 2001-04-01 |
| DK0468555T3 (da) | 1997-06-09 |
| IT9021104A1 (it) | 1992-01-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69123795D1 (de) | Pharmazeutische Zusammensetzung zur rektalen Verabreichung von Wirkstoffen mit topischer medizinischer Wirkung im Dickdarmniveau | |
| AU640137B2 (en) | Novel arylpyridazines, their manufacture, use and medicaments containing them | |
| DE69101931D1 (de) | Pharmazeutische Zusammensetzung. | |
| DE69115263D1 (de) | Pharmazeutische zusammensetzungen. | |
| DE19375061I2 (de) | Hexadecylphosphocolin enthaltende arzneimittel mit antitumorwirkung. | |
| ES2075468T3 (es) | Vehiculos de suministro de farmacos suspendidos en un portador perfluorado no acuoso. | |
| AR020662A1 (es) | Compuestos dihidrotiazoles policiclicos, procedimientos para su preparacion, medicamento, procedimiento para la preparacion de dicho medicamento y lautilizacion de dichos compuestos para la preparacion de un medicamento. | |
| FI922364L (fi) | Farmaceutiska kompositioner. | |
| SE8300736D0 (sv) | Novel pharmacologically active compounds | |
| IT8323205A0 (it) | Composizioni farmaceutiche adattivita' antiinfiammatoria e/o analgesica, non ulcerogene. | |
| IT8920486A0 (it) | Composizioni farmaceutiche. | |
| MX9102701A (es) | Derivados de 2-acilamido de 3,4-dihidro-3-oxo-quinoxalina que tienen actividad farmaceutica. | |
| DE59200277D1 (de) | Substituierte Diaminophthalimide und Analoga. | |
| DE3579730D1 (de) | Eisen-3-hydroxypyron- oder 3-hydroxypyridon-komplexe und diese enthaltende pharmazeutische zusammensetzungen. | |
| ATE97001T1 (de) | Topisch anzuwendende defibrotid enthaltende arzneizubereitungen. | |
| DE3576505D1 (de) | 3,4-dihydrobenzopyranverbindungen und diese enthaltende pharmazeutische zusammenstellungen. | |
| DE68905171D1 (de) | Benzol-derivate, ihre herstellung und pharmazeutische zusammensetzungen, die diese enthalten. | |
| DE3578597D1 (de) | 4-phenylphthalazin-derivate, deren herstellung und diese enthaltende pharmazeutische zusammenstellungen. | |
| ATE5256T1 (de) | Phenylpiperazinderivate von 1,3,4oxadiazolylphenolen, ihre herstellung und diese enthaltende therapeutische mittel. | |
| ATE106732T1 (de) | Arzneimittelzubereitung, enthaltend stigmasta-4- en-3-on sowie deren verwendung. | |
| ATE132877T1 (de) | Emulgatorfreie emulsionspolymere in pharmazeutischen zubereitungen mit verzögerter wirkstofffreigabe und ihre herstellung | |
| EP0729950A4 (de) | Anti-hiv arzneimittel | |
| DE3768109D1 (de) | Pharmazeutische zusammensetzungen. | |
| DE3484155D1 (de) | Fr-900216-verbindung, durch kultivierung von atcc 20577 gewonnen, als aktive therapeutische verbindung genutzt, und sie enthaltende antitumorale pharmazeutische zusammensetzung von fr-900216. | |
| MX9102627A (es) | Composicion farmaceutica de dobutamina para administracion transdermica. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EELA | Cancelled due to lapse of time |